Pharmacogenetics and Variability In Drug Exposure and Clinical Response to Corticosteroids in Severe BPD
Brief description of study
This observational study will follow infants born with a gestational age of less than 32 weeks requiring positive pressure ventilation and planned clinical treatment with corticosteroids for bronchopulmonary dysplasia.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
bronchopulmonary dysplasia,BPD
-
Age: - 1 Years
-
Gender: All
Infants less than 32 weeks at birth Infants treated with corticosteroids for BPD (per neonatal attending clinical discretion) Receiving positive pressure ventilation (NIV, CPAP or endotracheal tube mediated assisted ventilation) Less than 14 days of age, <180 days of age
Updated on
09 Mar 2024.
Study ID: 844677
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
